Novartis AG - 예탁증서(보통주)
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
주가
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSt Germain D J Co Inc
Latest Disclosed Ownership6,392 shares
Latest Disclosed Value $ 976,378
St Germain D J Co Inc ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 13, 2026 - St Germain D J Co Inc filed a 13F-HR form disclosing ownership of 6,392 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $821,372 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 6,392 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $773,432 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,392 0 0.00 976 10.78 0.0386
2026-01-29 2025-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,392 200 3.23 881 10.96 0.0342
2025-10-07 2025-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,192 21 0.34 794 6.43 0.0318
2025-07-16 2025-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,171 39 0.64 747 9.22 0.0322
2025-04-09 2025-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,132 -39 -0.63 684 13.83 0.0321
2025-01-10 2024-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,171 679 12.36 600 -4.91 0.0273
2024-10-18 2024-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,492 0 0.00 632 8.05 0.0290
2024-07-08 2024-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,492 0 0.00 585 9.98 0.0283
2024-04-02 2024-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,492 0 0.00 531 -4.15 0.0260
2024-01-02 2023-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,492 -38 -0.69 555 -1.60 0.0289
2023-10-23 2023-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,530 0 0.00 563 0.90 0.0317
2023-09-07 2023-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 5,530 -769 -12.21 558 685.92 0.0295
2023-02-27 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,299 785 14.24 71 -84.76 0.0240
2022-11-21 2022-09-30 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 466 0.00 0.0308
2022-08-15 2022-06-30 13F/A-1 Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 466 -3.72 0.0308
2022-08-12 2022-06-30 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 484 0.0272
2022-05-12 2022-03-31 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 484 0.41 0.0272
2022-02-11 2021-12-31 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 482 6.87 0.0265
2021-11-03 2021-09-30 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 451 -10.34 0.0278
2021-07-28 2021-06-30 13F Novartis AG Sponsored Adr COM 66987V109 5,514 0 0.00 503 6.79 0.0316
2021-05-13 2021-03-31 13F Novartis AG Sponsored Adr COM 66987V109 5,514 -70 -1.25 471 -10.63 0.0318
2021-02-04 2020-12-31 13F Novartis AG Sponsored Adr COM 66987V109 5,584 -63 -1.12 527 7.33 0.0376
2020-11-10 2020-09-30 13F Novartis AG Sponsored Adr COM 66987V109 5,647 0 0.00 491 -0.41 0.0398
2020-08-13 2020-06-30 13F Novartis AG Sponsored Adr COM 66987V109 5,647 115 2.08 493 8.11 0.0432
2020-05-13 2020-03-31 13F Novartis AG Sponsored Adr COM 66987V109 5,532 38 0.69 456 -12.31 0.0448
2020-02-14 2019-12-31 13F Novartis AG Sponsored Adr COM 66987V109 5,494 759 16.03 520 26.52 0.0437
2019-10-17 2019-09-30 13F Novartis AG Sponsored Adr COM 66987V109 4,735 0 0.00 411 -4.86 0.0442
2019-07-24 2019-06-30 13F Novartis AG Sponsored Adr COM 66987V109 4,735 0 0.00 432 -5.05 0.0471
2019-05-02 2019-03-31 13F Novartis AG Sponsored Adr COM 66987V109 4,735 0 0.00 455 12.07 0.0496
2019-02-05 2018-12-31 13F Novartis AG Sponsored Adr COM 66987V109 4,735 -30 -0.63 406 -1.22 0.0482
2018-10-23 2018-09-30 13F Novartis AG Sponsored Adr COM 66987V109 4,765 0 0.00 411 14.17 0.0460
2018-08-07 2018-06-30 13F Novartis AG Sponsored Adr COM 66987V109 4,765 615 14.82 360 7.14 0.0428
2018-04-20 2018-03-31 13F Novartis AG Sponsored Adr COM 66987V109 4,150 -2,857 -40.77 336 -42.86 0.0424
2018-02-13 2017-12-31 13F Novartis AG Sponsored Adr COM 66987V109 7,007 -185 -2.57 588 -4.70 0.0702
2017-10-31 2017-09-30 13F Novartis AG Sponsored Adr COM 66987V109 7,192 107 1.51 617 4.40 0.0773
2017-07-28 2017-06-30 13F Novartis AG Sponsored Adr COM 66987V109 7,085 492 7.46 591 20.61 0.0791
2017-04-25 2017-03-31 13F Novartis AG Sponsored Adr COM 66987V109 6,593 664 11.20 490 13.43 0.0682
2017-02-02 2016-12-31 13F Novartis AG Sponsored Adr COM 66987V109 5,929 567 10.57 432 2.13 0.0584
2016-10-27 2016-09-30 13F Novartis AG Sponsored Adr COM 66987V109 5,362 404 8.15 423 3.42 0.0591
2016-08-22 2016-06-30 13F Novartis AG Sponsored Adr COM 66987V109 4,958 459 10.20 409 25.46 0.0571
2016-04-21 2016-03-31 13F Novartis AG Sponsored Adr COM 66987V109 4,499 1,001 28.62 326 8.31 0.0466
2016-01-19 2015-12-31 13F Novartis AG Sponsored Adr COM 66987V109 3,498 3,498 301 0.0453
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.